Skip to main content
. 2021 Mar 19;13(6):1410. doi: 10.3390/cancers13061410

Figure 2.

Figure 2

Kaplan–Meier estimates show that overall survival/disease-free survival is worse in patients with high EP4 expression. (a) Kaplan–Meier survival univariate analysis for the status cytoplasmatic IRS ≥ 3. Positive expression of EP4 in the cytoplasm significantly reduced overall survival (p = 0.001) (b) Kaplan–Meier survival univariate analysis for the status cytoplasmatic IRS ≥ 3. Positive expression of EP4 lead to decreased disease-free survival (p = 0.069).